New hope for inoperable bile duct cancer: targeted therapies aim to shrink tumors
NCT ID NCT06313203
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests two treatments for a type of bile duct cancer that cannot be surgically removed. One delivers chemotherapy directly to the liver through a pump, and the other uses tiny radioactive beads injected into the tumor's blood supply. Both are given alongside standard chemotherapy. The goal is to see if these combinations can shrink tumors enough to allow surgery or help patients live longer. About 39 people will take part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Floxuridine (via hepatic artery infusion) and Yttrium-90 radioactive particles (via selective internal radiation therapy)
What this could lead to
If successful, this could offer a way to shrink inoperable bile duct tumors enough for surgery, potentially improving survival and giving more patients a chance at a cure.
What could go wrong
This is a small, early-phase trial (39 people) without randomization, so results may not apply broadly. Both treatments have risks like liver damage or infection, and the floxuridine arm requires frequent hospital visits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAHEPATIC CHOLANGIOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Oslo University Hospital
RECRUITINGOslo, Oslo, 0424, Norway
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••